C.M. Bidwell & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
C.M. Bidwell & Associates's LLY Position: Q1 2026 in Review
C.M. Bidwell & Associates opened a new position in Eli Lilly (LLY) in Q1 2026: 262 shares worth $241K. The stake represents 0.11% of the portfolio and ranks #121 among its holdings. This is a return to the name: C.M. Bidwell & Associates previously reported a position in LLY as recently as Q3 2024.
C.M. Bidwell & Associates first reported a position in LLY in Q4 2016 and has held it in 19 quarters since. The position peaked at $4.4M in Q1 2017. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- C.M. Bidwell & Associates held 262 shares of Eli Lilly worth $241K as of Q1 2026.
- Eli Lilly was a new C.M. Bidwell & Associates position in Q1 2026.
- Eli Lilly made up 0.11% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #121 holding.
- C.M. Bidwell & Associates first reported a position in Eli Lilly in Q4 2016 and has held it in 19 quarters since.
- C.M. Bidwell & Associates's Eli Lilly position peaked at $4.4M in Q1 2017.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.